Head-to-Head: which lupus drug works better?
Disease control
Not yet recruiting
This study compares two drugs, telitacicept and belimumab, for controlling systemic lupus erythematosus (SLE) in 180 adults aged 18-65. Participants choose their treatment with their doctor. The goal is to see which drug better reduces lupus activity and improves kidney outcomes.…
Sponsor: Yipeng Liu • Aim: Disease control
Last updated May 22, 2026 14:01 UTC